Detalles de la búsqueda
1.
Fertility preservation in lymphoma patients treated with immunochemotherapy regimens with or without radiotherapy: results of a retrospective multicenter Italian study (Ferty care).
Leuk Lymphoma;
: 1-8, 2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38847543
2.
End of induction [18F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.
Eur J Nucl Med Mol Imaging;
2024 May 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38795120
3.
Management of vaccinations in patients with non-Hodgkin lymphoma.
Br J Haematol;
204(5): 1617-1634, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38532527
4.
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Haematologica;
2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38497158
5.
IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
Haematologica;
2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38385243
6.
MYC rearrangements in HIV-associated large B-cell lymphomas: EUROMYC, a European retrospective study.
Blood Adv;
8(4): 968-977, 2024 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38207206
7.
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies.
Leuk Lymphoma;
65(4): 460-471, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164812
8.
Fertility preservation and monitoring in adult patients diagnosed with lymphoma: consensus-based practical recommendations by the Fondazione Italiana Linfomi & Società Italiana della Riproduzione Umana.
Front Oncol;
13: 1252433, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37766870
9.
Pixantrone as bridging therapy to allogeneic transplantation or in chimeric antigen receptor T-cell pathway in patients with diffuse large B-cell lymphoma.
Hematol Oncol;
41(5): 947-950, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37442805
10.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Blood;
142(17): 1438-1447, 2023 10 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37418685
11.
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma.
Blood Adv;
7(15): 4160-4169, 2023 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37276080
12.
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
Hematol Oncol;
41(4): 655-662, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246287
13.
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Hemasphere;
7(4): e837, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37034003
14.
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Br J Haematol;
201(4): 653-662, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36733229
15.
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Haematologica;
108(4): 1083-1091, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36384247
16.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Hematol Oncol;
41(1): 78-87, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36177902
17.
Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
Cancers (Basel);
14(23)2022 Dec 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36497442
18.
First-line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes.
EJHaem;
3(2): 415-425, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35846037
19.
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study.
Cancers (Basel);
14(3)2022 Jan 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35158922
20.
Brentuximab Vedotin and Bendamustine Produce Long-Term Clinical Benefit in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma: A Multicenter Real-Life Experience.
Clin Lymphoma Myeloma Leuk;
22(3): 198-204, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34690088